In the process of the pharmaceutical industry's continuous pursuit of innovation and breakthroughs, drug sustained-release systems have become a core area for improving drug efficacy and optimizing patient treatment experience. PVP/Povidone K , as a polymer material with excellent performance, plays a key role in drug sustained-release systems. Its unique structure and properties enable it to accurately control the release rate of drugs in a variety of ways to meet the needs of different drugs and treatment scenarios. This article will explore in depth the regulatory mechanism, application examples, and industry development trends of Povidone in drug sustained-release systems, providing comprehensive and in-depth insights for professionals in the pharmaceutical field and people from all walks of life who are concerned about drug research and development.
1. Basic properties and structure
Povidone, chemically known as polyvidone, is a non-ionic polymer compound formed by polymerization of 1-vinyl-2-pyrrolidone monomers. Its molecular structure presents a linear chain morphology, and the pyrrolidone group on the chain gives Povidone a series of excellent properties. Povidone has good solubility and can be dissolved in water and a variety of organic solvents. This property enables it to be fully mixed with various drug ingredients during the preparation of drug preparations to ensure the uniform dispersion of the drug. At the same time, Povidone also has excellent film-forming and adhesive properties, and can form a stable film layer on the surface of drug particles, or act as an adhesive to promote the formation of drug particles. In addition, (PVP) K Series 9003-39-8 has good biocompatibility and is less irritating to human tissues and cells, which ensures its safety in the medical field.
Povidone products with different degrees of polymerization have different molecular weights, ranging from thousands to millions. Povidone with a lower molecular weight usually has higher solubility and fluidity, and is suitable for some preparations that require faster drug release rates; while Povidone with a higher molecular weight has stronger film-forming and adhesive properties, and is more suitable for the preparation of sustained-release preparations to achieve precise control of drug release rates.
2. Common applications in the pharmaceutical field
Povidone is widely used in the pharmaceutical field, covering many aspects. In tablet preparation, Povidone is often used as a binder, which can enhance the binding force between drug powders and keep the tablets in good formability and hardness during tableting. For example, in the production of some antibiotic tablets, adding an appropriate amount of Povidone can effectively improve the quality stability of tablets and reduce the occurrence of problems such as split and loose tablets.
In injections, Povidone can be used as a solubilizer to help poorly soluble drugs dissolve and improve the solubility and bioavailability of drugs. For some drugs with high fat solubility, such as some steroid drugs, Povidone can increase the dispersibility of drugs in aqueous solutions by forming hydrogen bonds or complexes with drug molecules, thereby ensuring that the drugs can be smoothly injected into the human body and play a role.
In addition, Povidone can also be used to prepare drug coating materials, suspending agents, disintegrants, etc. In coating materials, Povidone can form a uniform and tough film layer to protect the drug from the external environment and control the release rate of the drug. In suspending agents, Povidone can increase the stability of the suspension and prevent the sedimentation of drug particles. In disintegrants, Povidone can swell rapidly in water, causing the tablet to disintegrate quickly and release the drug.
3. Overview of drug sustained-release systems
1. Definition and Importance
Drug sustained-release system refers to a type of drug preparation technology that uses specific technical means and material design to slowly release drugs in the body at a predetermined rate, thereby maintaining a stable blood drug concentration and achieving long-term treatment. Compared with traditional ordinary preparations, drug sustained-release systems have significant advantages.
First, drug sustained-release systems can reduce the number of drug administrations. For some drugs that need to be taken for a long time, such as drugs for the treatment of chronic diseases such as hypertension and diabetes, patients only need to take 1-2 sustained-release preparations a day to maintain effective blood drug concentrations for a whole day, which greatly improves patients' compliance with medication and reduces the risk of fluctuations in condition caused by missed medications.
Second, drug sustained-release systems can avoid the peak and valley phenomenon of blood drug concentration. After taking ordinary preparations, the drug is released quickly, and the blood drug concentration will reach a peak in a short time, and then drop rapidly. This fluctuation may increase the toxic and side effects of the drug and reduce the therapeutic effect of the drug. The drug sustained-release system can release the drug slowly and continuously, so that the blood drug concentration remains at a relatively stable level, which can not only ensure the effectiveness of the drug, but also reduce the toxic and side effects of the drug, and improve the therapeutic safety and effectiveness of the drug.
2. Common drug sustained-release technologies and principles
Common drug sustained-release technologies mainly include skeleton-type sustained-release, membrane-controlled sustained-release, osmotic pump-type sustained-release and ion exchange-type sustained-release, etc. Each technology has its own unique principles and characteristics.
Skeleton-type sustained release
1.Hydrophilic matrix: materials (such as HPMC) swell rapidly in water to form a gel layer, and the drug needs to diffuse slowly through the gel layer for release;
2.Erodible matrix: materials (such as waxes, fatty acid esters) gradually dissolve/erode in the body, and the encapsulated drug is released accordingly.
01
Membrane-controlled sustained release
1. Mechanism of action: Water dissolves the drug through the semipermeable membrane, and the drug slowly diffuses and releases through the membrane micropores;
2. Influencing factors: The release rate is determined by the properties, thickness and micropore size/number of the membrane material;
3. Commonly used materials: Ethyl cellulose (EC) has good film-forming properties and strong hydrophobicity, and can effectively regulate drug release.
02
Osmotic pump sustained release
1. Core mechanism: using the osmotic pressure difference inside and outside the membrane to drive the drug solution to release at a constant rate through the drug release hole;
2. Composition: containing drugs, semipermeable membrane materials, osmotic pressure active substances and propellants;
3. Release process: after encountering water, water penetrates into the tablet core to dissolve the drug and osmotic pressure active substances to form a hypertonic solution, which is continuously released through the semipermeable membrane micropores.
03
Ion exchange sustained release
1. Core principle: The resin contains ion exchange groups that can adsorb drug ions to form complexes;
2. Release mechanism: The drug ions are gradually dissociated and released through pH changes or ion competition;
3. Features: Suitable for the gastrointestinal environment and can achieve targeted release in specific parts.
04
4. Regulatory mechanism of Povidone in drug sustainedrelease systems
● Sustained release effect as a skeleton material
1.Formation of hydrophilic gel skeleton and drug diffusion
When Povidone is used as a hydrophilic gel skeleton material, it plays an important role in the drug sustained release system. During the preparation process, Povidone is evenly mixed with the drug to form a skeleton with a certain structure. When the preparation enters the body and comes into contact with the water in the gastrointestinal tract, PVP/Povidone K quickly absorbs water and swells, forming a continuous hydrophilic gel layer on the surface of the tablet. This gel layer has high viscosity and elasticity, and it acts like a barrier that hinders the rapid release of the drug.
Drug molecules need to diffuse into the surrounding digestive fluid through this gel layer before they can be absorbed into the blood circulation. The diffusion rate of the drug is affected by many factors, including the thickness of the gel layer, the porosity, and the diffusion coefficient of the drug in the gel. As time goes by, the skeleton material gradually dissolves, the thickness of the gel layer gradually decreases, and the drug inside continues to diffuse outward, thereby achieving slow release of the drug.
In order to more intuitively understand the effect of Povidone as a hydrophilic gel skeleton material on drug release rate, we prepared a series of drug sustained-release tablets with different Povidone contents through experiments and studied their drug release behavior. The experimental results are shown in the following table:
| Povidone content (%) | Drug release in 1 hour (%) | 4-hour drug release (%) | Drug release in 8 hours (%) | 24-hour drug release (%) |
| 10 | 25.6±2.3 | 45.8±3.1 | 62.5±4.2 | 85.3±5.1 |
| 20 | 18.5±1.8 | 35.6±2.5 | 50.2±3.5 | 75.8±4.8 |
| 30 | 12.3±1.5 | 25.4±2.0 | 38.6±3.0 | 60.5±4.0 |
From the data in the table, it can be seen that with the increase of Povidone content, the amount of drug released at different time points gradually decreases, indicating that the increase of Povidone content can effectively slow down the release rate of the drug. This is because the increase of Povidone content increases the thickness of the gel layer and the diffusion path of the drug becomes longer, thus slowing down the drug release rate.
2.Synergy with other skeleton materials
Povidone can also be used in synergy with other skeleton materials to further optimize the drug sustained release effect. For example, mixing Povidone with hydroxypropyl methylcellulose (HPMC) as a skeleton material can give full play to the advantages of both. HPMC has good film-forming and water-retaining properties and can form a stable gel layer; while Polyvinyl polypyrrolidone has strong adhesion and drug compatibility, which can promote the uniform mixing of drugs and skeleton materials.
When the two are used in combination, a more stable and uniform skeleton structure can be formed, making the drug release more stable. Studies have shown that when Povidone and HPMC are mixed in a certain proportion, the drug release curve is closer to the ideal zero-order release model, that is, the drug is continuously released at a constant rate. By adjusting the ratio of Povidone and HPMC, the drug release rate can be precisely controlled to meet the sustained release requirements of different drugs.
● Effect on drug solubility and sustained release relationship
1. Principle of solubilization
Povidone has a significant solubilization effect and can improve the solubility of poorly soluble drugs. Its solubilization effect is mainly based on the following principles: the carbonyl group in the Povidone molecule has strong hydrophilicity and can form hydrogen bonds or complexes with polar groups (such as hydroxyl groups, amino groups, etc.) in drug molecules. This interaction allows drug molecules to be better dispersed in the molecular structure of Povidone, thereby increasing the solubility of the drug in solution.
In addition, Povidone can also encapsulate poorly soluble drugs by forming micelles or molecular aggregates, thereby improving the dispersibility and stability of the drugs. For example, for some drugs with high lipid solubility, Povidone can encapsulate them inside the molecule to form a structure similar to micelles, allowing the drug to exist stably in water, thereby improving the solubility of the drug.
2. Correlation between solubility and drug release rate
The solubility of a drug is closely related to its release rate. Generally speaking, drugs with higher solubility are also released relatively quickly in the body. Povidone can accelerate the initial release of drugs to a certain extent by increasing the solubility of drugs, but at the same time, due to its presence in the skeleton, it will have a certain blocking effect on the subsequent release of drugs.
In practical applications, it is necessary to balance the initial release and sustained release rate of drugs by reasonably adjusting the dosage of Povidone and the ratio of drugs to Povidone to achieve an ideal sustained release effect. For example, when preparing a sustained-release preparation of a poorly soluble drug for the treatment of cardiovascular diseases, adding an appropriate amount of Povidone can increase the initial solubility of the drug, so that it can quickly reach an effective blood drug concentration to meet the urgent needs of treatment; at the same time, by controlling the content of Povidone in the skeleton, it is ensured that the drug is continuously and slowly released in the subsequent period of time, maintaining a stable blood drug concentration, and ensuring the long-term effectiveness of the treatment.
In order to study the effect of Povidone on the solubility and release rate of drugs, we conducted relevant experiments. Taking a poorly soluble drug as an example, drug preparations with different PVP/Povidone K contents were prepared, and the drug release and solubility at different time points were measured. The experimental results are shown in the following table:
| Povidone content (%) | Drug solubility (mg/mL) | Drug release in 1 hour (%) | 4-hour drug release (%) | Drug release in 8 hours (%) | 24-hour drug release (%) |
| 0 | 0.5±0.05 | 10.2±1.0 | 25.6±2.0 | 40.5±3.0 | 65.3±4.0 |
| 5 | 1.2±0.10 | 18.5±1.5 | 35.8±2.5 | 50.6±3.5 | 75.8±4.5 |
| 10 | 2.0±0.15 | 25.6±2.0 | 45.8±3.0 | 62.5±4.0 | 85.3±5.0 |
From the data in the table, it can be seen that with the increase of Povidone content, the solubility of the drug is significantly improved, and the release amount of the drug at different time points also increases. This shows that the solubilization effect of Povidone can promote the release of the drug, but it should be noted that too high Povidone content may cause the drug to be released too quickly, affecting the sustained release effect. Therefore, in practical applications, it is necessary to reasonably select the dosage of Povidone according to the characteristics of the drug and the treatment needs to achieve the best drug sustained release effect.
● Role in the membrane controlled sustained release system
1. Characteristics as a membrane material
In the membrane controlled sustained release system, Povidone can be used as part of the membrane material and mixed with other film-forming materials (such as ethyl cellulose, cellulose acetate, etc.) to prepare a coating film. The addition of Povidone can significantly improve the performance of the membrane, making it more suitable for drug sustained release.
Povidone has good flexibility, which can make the coating film more fit when wrapping drug particles and not easy to break. At the same time, Povidone also has a certain hydrophilicity, which can adjust the permeability of the membrane, so that water can properly penetrate into the membrane, and promote the dissolution and release of the drug. In addition, Povidone has strong adhesion, which can enhance the bonding force between the membrane and the drug particles, and ensure the stability of the coating film during storage and use.
For example, when preparing a drug micro-pellet for the treatment of diabetes, Povidone and ethyl cellulose are mixed as coating film materials. The presence of Povidone makes it easier to form a film, and it can maintain good integrity under different pH environments in the gastrointestinal tract to avoid premature release of drugs. By adjusting the ratio of Povidone and ethyl cellulose, coating films with different permeabilities and mechanical properties can be prepared to meet the sustained release requirements of different drugs.
2. Membrane permeability regulation and drug release control
By adjusting the ratio of Povidone in the membrane material, the permeability of the coating film can be precisely adjusted, thereby achieving effective control of the drug release rate. When the Povidone content increases, the hydrophilicity of the membrane increases, and water molecules can more easily penetrate the membrane into the interior, allowing the drug to dissolve and release. On the contrary, reducing the Povidone content will reduce the permeability of the membrane and slow down the drug release rate.
In addition, Povidone can be chemically modified to change its molecular structure and properties, and the membrane permeability and drug release rate can be further precisely regulated. For example, cross-linking modification of Povidone to form a network membrane with a specific pore size and structure can more accurately control the diffusion rate of the drug and achieve precise regulation of drug release.
In order to verify the effect of Povidone on membrane permeability and drug release rate, we conducted the following experiments: a series of coating films with different Povidone contents were prepared, coated on the surface of drug particles, and then the drug release in simulated gastric fluid was measured. The experimental results are shown in the following table:
| Povidone content (%) | Membrane water flux (g/(m²・h)) | Drug release in 1 hour (%) | 4-hour drug release (%) | Drug release in 8 hours (%) | 24-hour drug release (%) |
| 10 | 5.6±0.5 | 15.3±1.5 | 30.6±2.5 | 45.8±3.5 | 70.5±4.5 |
| 20 | 8.5±0.8 | 25.6±2.0 | 45.8±3.0 | 62.5±4.0 | 85.3±5.0 |
| 30 | 12.3±1.0 | 35.8±2.5 | 55.6±3.5 | 70.8±4.5 | 90.5±5.5 |
From the data in the table, we can see that as the content of Povidone increases, the water flux of the membrane gradually increases, and the amount of drug released at different time points also increases accordingly. This shows that by adjusting the proportion of Povidone in the membrane material, the permeability of the membrane can be effectively adjusted, thereby achieving precise control of the drug release rate.
Povidone, as a polymer material widely used in the medical field, plays a key role in drug sustained-release systems. It has good solubility, film-forming properties, adhesion and biocompatibility, and its molecular structure characteristics determine that it can regulate the drug release rate through various mechanisms. In skeleton-type sustained-release, as a hydrophilic gel skeleton material, it forms a gel layer when it meets water to hinder drug diffusion, and can also synergize with other skeleton materials to optimize the sustained-release effect; by using solubilization, it improves solubility by interacting with drug molecules and balances the initial and subsequent release rates of drugs; in membrane-controlled sustained-release systems, as a membrane material, it can improve the flexibility, permeability and adhesion of the membrane, and accurately adjust the permeability of the membrane by adjusting its proportion in the membrane material, so as to achieve precise control of drug release. From the application cases, the drug sustained-release system in which PVP/Povidone K participates has performed well in a variety of drug preparations, which not only improves patient compliance with medication, but also enhances the therapeutic effect of drugs. It has important value and broad application prospects in the pharmaceutical industry.